Biomarker Study Accompanying the AIO-TRK-0114 Study (MARBLE)
Status:
Terminated
Trial end date:
2017-11-20
Target enrollment:
Participant gender:
Summary
To compare the efficacy of afatinib maintenance with pemetrexed maintenance following
induction therapy with platinum/ pemetrexed in patients with metastatic EGFR mutated
non-small-cell lung cancer progressing after first-line treatment with afatinib as first
tyrosine kinase inhibitor with respect to progression-free survival